October Science Corner
ALS Champions Head to Washington as FDA Issues Guidance Document for Potential ALS Treatments
On September 23, 2019, the Food and Drug Administration (FDA) issued its most recent guidance document for the development of potential treatments for ALS. Many representatives of the ALS community – patient advocates like our friends Phil Green and Matt Bellina, researchers, organizations like Augie’s Quest, ALS TDI, Team Gleason and IamALS – gathered in Washington to collaborate with government officials to help fast-track the funding, clinical research design, and focus needed to uncover effective treatments and an ultimate cure for this disease.
You can read general takeaways and the entire guidance document here via our research partners at the ALS Therapy Development Institute.